ACHC Q1 2026 Earnings Call Summary

Acadia Healthcare (ACHC) Q1 2026 Earnings Call Summary

1. Key Financial Results and Metrics

Revenue: $828.8 million, a 7.6% increase year-over-year.
Same-Facility Revenue: Grew 7.3%, driven by a 5.6% increase in revenue per patient day and a 1.6% increase in patient days.
Adjusted EBITDA: $144.2 million, up 7.5% from Q1 2025, exceeding guidance by $7.2 million.
Free Cash Flow: Negative $15 million, though improved by $148 million compared to Q1 2025.
Net Leverage Ratio: Approximately 3.9x adjusted EBITDA as of March 31, 2026.
Patient Volume: Increased inpatient volumes by 6.2%, with acute inpatient psychiatric facilities growing 14%.

2. Strategic Updates and Business Highlights

Operational Focus: Emphasis on operational execution and leadership restructuring to enhance performance across facilities.
New Facilities: Opened a joint venture facility in Greater Boston and plans to open two more in Q2 2026.
Bed Additions: Added 82 beds in Q1, with plans to add 400-600 beds throughout 2026.
Referral Relationships: Strengthened referral networks, particularly in surrounding states, to mitigate challenges in Pennsylvania.
Technology Investments: Continued investment in technology and data tools to improve operational efficiency and patient care.

3. Forward Guidance and Outlook

Q2 2026 Guidance: Expected revenue between $835 million and $850 million, adjusted EBITDA of $142 million to $152 million, and adjusted EPS of $0.30 to $0.40.
Full-Year 2026 Guidance: Revenue remains at $3.37 billion to $3.45 billion; adjusted EBITDA guidance increased to $580 million to $615 million; adjusted EPS guidance raised to $1.35 to $1.60.
Supplemental Payments: Anticipated increase in supplemental payments in the back half of the year, with potential regulatory approvals for additional programs that could add at least $22 million in EBITDA.

4. Bad News, Challenges, or Points of Concern

Specialty Facility Revenue Decline: Revenue from specialty facilities decreased by 6.5%, impacted by closures and challenges in Pennsylvania.
Payer Denials and Bad Debt: Increased levels of bad debts and denials, which were worse than expected, affecting overall financial performance.
Start-Up Losses: Continued losses from start-up facilities, with expectations of $15 million in Q2, although improvements are anticipated in the back half of the year.
Weather Impact: Severe winter weather in Q1 negatively impacted CTC revenue growth and overall adjusted EBITDA by $3.7 million.

5. Notable Q&A Insights

Referral Network Enhancements: Management is actively working to strengthen referral relationships and improve patient outcomes, with a focus on tailored action plans for underperforming facilities.
Bad Debt Management: Strategies are in place to address payer denials, including improved documentation processes and hiring of consultants to enhance revenue cycle management.
Operational Restructuring: The leadership changes aim to streamline operations and improve decision-making efficiency, with a focus on aligning corporate support with facility needs.
Patient Care Metrics: Emphasis on patient satisfaction, improved clinical outcomes, and readmission rates as key performance indicators to demonstrate quality of care to payers.

Overall, Acadia Healthcare reported a solid start to 2026, with strong revenue growth and operational improvements, although challenges remain in specialty revenue and payer relationships. The company is focused on executing its strategic initiatives to enhance performance and address ongoing challenges.

ACHC — Acadia Healthcare Company, Inc.